Document is current
Any future updates will be listed below
-
Authors
Brenner, Jacob S. https://orcid.org/0000-0001-8437-0161
Pan, Daniel C.
Myerson, Jacob W. https://orcid.org/0000-0002-5686-8437
Marcos-Contreras, Oscar A.
Villa, Carlos H. https://orcid.org/0000-0002-4632-4751
Patel, Priyal
Hekierski, Hugh
Chatterjee, Shampa
Tao, Jian-Qin
Parhiz, Hamideh
Bhamidipati, Kartik
Uhler, Thomas G.
Hood, Elizabeth D.
Kiseleva, Raisa Yu. https://orcid.org/0000-0001-8065-3551
Shuvaev, Vladimir S.
Shuvaeva, Tea
Khoshnejad, Makan
Johnston, Ian
Gregory, Jason V.
Lahann, Joerg
Wang, Tao https://orcid.org/0000-0002-4396-7188
Cantu, Edward
Armstead, William M.
Mitragotri, Samir
Muzykantov, Vladimir
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1RO1 HL125462-02)
- License Information
-
More Information
Article History
Received: 24 October 2017
Accepted: 31 May 2018
First Online: 11 July 2018
Competing interests
: The following competing financial interests are declared: five of the authors (J.S.B., D.C.P., J.W.M., V.R.M., and S.M.) are listed on a patent application submitted by the University of Pennsylvania, U.S. patent application number 15/722,583, which covers the use of RBC-hitchhiking nanocarriers for the treatment of disease. The remaining authors declare no competing interests.
